These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
363 related items for PubMed ID: 12879282
1. Pharmacokinetics and tissue distribution of intraperitoneal paclitaxel with different carrier solutions. Mohamed F, Marchettini P, Stuart OA, Sugarbaker PH. Cancer Chemother Pharmacol; 2003 Nov; 52(5):405-10. PubMed ID: 12879282 [Abstract] [Full Text] [Related]
2. Pharmacokinetics and tissue distribution of intraperitoneal docetaxel with different carrier solutions. Mohamed F, Stuart OA, Sugarbaker PH. J Surg Res; 2003 Jul; 113(1):114-20. PubMed ID: 12943819 [Abstract] [Full Text] [Related]
3. Docetaxel: pharmacokinetics and tissue levels after intraperitoneal and intravenous administration in a rat model. Marchettini P, Stuart OA, Mohamed F, Yoo D, Sugarbaker PH. Cancer Chemother Pharmacol; 2002 Jun; 49(6):499-503. PubMed ID: 12107555 [Abstract] [Full Text] [Related]
7. Hyperthermia modifies pharmacokinetics and tissue distribution of intraperitoneal melphalan in a rat model. Glehen O, Stuart OA, Mohamed F, Sugarbaker PH. Cancer Chemother Pharmacol; 2004 Jul; 54(1):79-84. PubMed ID: 15048586 [Abstract] [Full Text] [Related]
8. Different tissue distribution of paclitaxel with intravenous and intraperitoneal administration. Soma D, Kitayama J, Ishigami H, Kaisaki S, Nagawa H. J Surg Res; 2009 Jul; 155(1):142-6. PubMed ID: 19328496 [Abstract] [Full Text] [Related]
9. Pharmacokinetics and tissue distribution of intraperitoneal 5-fluorouracil with a novel carrier solution in rats. Wei ZG, Li GX, Huang XC, Zhen L, Yu J, Deng HJ, Qing SH, Zhang C. World J Gastroenterol; 2008 Apr 14; 14(14):2179-86. PubMed ID: 18407591 [Abstract] [Full Text] [Related]
10. Dosing sequence-dependent pharmacokinetic interaction of oxaliplatin with paclitaxel in the rat. Liu J, Kraut EH, Balcerzak S, Grever M, D'Ambrosio S, Chan KK. Cancer Chemother Pharmacol; 2002 Dec 14; 50(6):445-53. PubMed ID: 12451470 [Abstract] [Full Text] [Related]
11. Influence of Cremophor El on the bioavailability of intraperitoneal paclitaxel. Gelderblom H, Verweij J, van Zomeren DM, Buijs D, Ouwens L, Nooter K, Stoter G, Sparreboom A. Clin Cancer Res; 2002 Apr 14; 8(4):1237-41. PubMed ID: 11948138 [Abstract] [Full Text] [Related]
12. Amphotericin B does not increase peritoneal fluid removal. Wang T, Heimbürger O, Cheng HH, Bergström J, Lindholm B. Adv Perit Dial; 1998 Apr 14; 14():3-10. PubMed ID: 10649681 [Abstract] [Full Text] [Related]
13. Plasma and tissue disposition of paclitaxel (taxol) after intraperitoneal administration in mice. Innocenti F, Danesi R, Di Paolo A, Agen C, Nardini D, Bocci G, Del Tacca M. Drug Metab Dispos; 1995 Jul 14; 23(7):713-7. PubMed ID: 7587959 [Abstract] [Full Text] [Related]
19. Hypertonic-hyperoncotic solutions improve cardiac function in children after open-heart surgery. Schroth M, Plank C, Meissner U, Eberle KP, Weyand M, Cesnjevar R, Dötsch J, Rascher W. Pediatrics; 2006 Jul 14; 118(1):e76-84. PubMed ID: 16751617 [Abstract] [Full Text] [Related]
20. Surfactants influence the distribution of taxanes in peritoneal dissemination tumor-bearing rats. Kamijo Y, Ito C, Nomura M, Sai Y, Miyamoto K. Cancer Lett; 2010 Jan 28; 287(2):182-6. PubMed ID: 19608331 [Abstract] [Full Text] [Related] Page: [Next] [New Search]